| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
ELTX
Elicio Therapeutics
|
Jun 10, 2026 | BUY |
Buy
+380.1% avg upside
11 analysts
|
$27.00
601.22% Upside
|
· |
|
AAPG
Ascentage Pharma Group International Unsponsored ADR
|
Jun 10, 2026 | BUY |
Strong Buy
+156.4% avg upside
10 analysts
|
$45.00
162.91% Upside
|
· |
|
AVBP
ArriVent BioPharma, Inc.
|
May 29, 2026 | BUY |
Strong Buy
+37.1% avg upside
15 analysts
|
$45.00
41.83% Upside
|
+3.6% |
|
MGNX
MacroGenics
|
May 22, 2026 | BUY |
Buy
+326.4% avg upside
25 analysts
|
$9.00
118.00% Upside
|
· |
|
NUVB
Nuvation Bio
|
May 21, 2026 | BUY |
Strong Buy
+132.2% avg upside
15 analysts
|
$12.00
115.84% Upside
|
+11.3% |
|
HROW
Harrow Health
|
May 14, 2026 | BUY |
Strong Buy
+25.5% avg upside
12 analysts
|
$60.00
40.01% Upside
|
+35.9% |
|
UNCY
Unicycive Therapeutics
|
May 01, 2026 | BUY |
Strong Buy
+708.7% avg upside
10 analysts
|
$22.00
221.12% Upside
|
+5.3% |
|
ZYME
Zymeworks
|
Apr 10, 2026 | BUY |
Strong Buy
+40.3% avg upside
25 analysts
|
$40.00
72.85% Upside
|
-14.5% |
|
NVAX
Novavax
|
Apr 09, 2026 | BUY |
Buy
+154.0% avg upside
20 analysts
|
$18.00
97.23% Upside
|
+4.0% |
|
PDSB
PDS Biotechnology
|
Apr 07, 2026 | BUY |
Strong Buy
+1493.1% avg upside
11 analysts
|
$3.00
214.23% Upside
|
+4.6% |
|
TBPH
Theravance Biopharma
|
Apr 07, 2026 | HOLD |
Buy
+12.2% avg upside
18 analysts
|
$17.00
2.47% Upside
|
+0.9% |
|
CNTA
Centessa Pharmaceuticals
|
Mar 31, 2026 | HOLD |
Buy
-14.4% avg upside
19 analysts
|
$45.00
12.42% Upside
|
+0.3% |
|
DERM
Journey Medical Corp
|
Mar 26, 2026 | BUY |
Strong Buy
+98.3% avg upside
11 analysts
|
$12.00
92.89% Upside
|
+27.8% |
|
LCTX
Lineage Therap
|
Mar 25, 2026 | BUY |
Strong Buy
+342.7% avg upside
16 analysts
|
$4.00
230.49% Upside
|
-21.9% |
|
CLYM
Climb Bio
|
Mar 24, 2026 | BUY |
Strong Buy
+57.9% avg upside
18 analysts
|
$26.00
126.98% Upside
|
+61.7% |
|
ARCT
Arcturus Therapeutics
|
Mar 18, 2026 | BUY |
Buy
+291.8% avg upside
35 analysts
|
$22.00
192.15% Upside
|
+28.2% |
|
DNLI
Denali Therapeutics
|
Mar 13, 2026 | BUY |
Strong Buy
+60.2% avg upside
24 analysts
|
$30.00
28.69% Upside
|
+6.6% |
|
CYTK
Cytokinetics
|
Mar 10, 2026 | BUY |
Strong Buy
+8.9% avg upside
36 analysts
|
$108.00
37.12% Upside
|
+23.0% |
|
NKTR
Nektar Therapeutics
|
Feb 23, 2026 | BUY |
Strong Buy
+16.6% avg upside
25 analysts
|
$150.00
146.05% Upside
|
-17.2% |
|
KYMR
Kymera Therapeutics
|
Dec 22, 2025 | BUY |
Strong Buy
+9.0% avg upside
36 analysts
|
$117.00
29.35% Upside
|
+6.6% |
|
CRBP
Corbus Pharmaceuticals
|
Oct 06, 2025 | BUY |
Strong Buy
+338.6% avg upside
20 analysts
|
$28.00
239.08% Upside
|
-24.0% |
|
SNDX
Syndax Pharmaceuticals
|
Oct 03, 2025 | BUY |
Strong Buy
+88.7% avg upside
27 analysts
|
$33.00
73.76% Upside
|
+17.4% |
|
TGTX
TG Therapeutics
|
Sep 17, 2025 | BUY |
Strong Buy
-34.3% avg upside
19 analysts
|
$55.00
3.37% Upside
|
+57.7% |
|
ACTU
Actuate Therapeutics, Inc.
|
Aug 26, 2025 | BUY |
Strong Buy
+528.6% avg upside
4 analysts
|
$20.00
866.12% Upside
|
-75.3% |
|
INKT
MiNK Therapeutics
|
Aug 19, 2025 | BUY |
Strong Buy
+81.2% avg upside
6 analysts
|
$43.00
254.23% Upside
|
-23.2% |
|
TRVI
Trevi Therapeutics
|
Aug 14, 2025 | BUY |
Strong Buy
+17.9% avg upside
16 analysts
|
$16.00
7.03% Downside
|
+89.6% |
|
ALT
Altimmune
|
Aug 13, 2025 | BUY |
Strong Buy
+935.8% avg upside
19 analysts
|
$18.00
566.62% Upside
|
-22.5% |
|
VKTX
Viking Therapeutics
|
Jul 15, 2025 | BUY |
Strong Buy
+141.1% avg upside
30 analysts
|
$85.00
179.85% Upside
|
-3.4% |
|
AGEN
Agenus
|
Jul 01, 2025 | BUY |
Strong Buy
+165.3% avg upside
17 analysts
|
$8.00
166.75% Upside
|
-26.0% |
|
ARWR
Arrowhead Pharmaceuticals
|
May 14, 2025 | BUY |
Strong Buy
-19.1% avg upside
26 analysts
|
$38.00
53.55% Downside
|
+399.8% |
|
MDGL
Madrigal Pharmaceuticals
|
May 02, 2025 | BUY |
Strong Buy
-5.8% avg upside
31 analysts
|
$460.00
9.12% Downside
|
+52.4% |
|
VXRT
Vaxart
|
Mar 27, 2025 | BUY |
Strong Buy
+1311.1% avg upside
8 analysts
|
$2.00
263.00% Upside
|
+65.2% |
|
CGTX
Cognition Therapeutics
|
Feb 06, 2025 | BUY |
Strong Buy
+305.1% avg upside
9 analysts
|
$2.00
37.85% Upside
|
+89.1% |
|
ETON
Eton Pharmaceuticals
|
Jan 09, 2025 | BUY |
Strong Buy
-21.5% avg upside
8 analysts
|
$21.00
35.33% Downside
|
+143.8% |
|
FBIO
Fortress Biotech
|
Jul 05, 2024 | HOLD |
Strong Buy
+163.3% avg upside
12 analysts
|
— | +33.9% |
|
TLSA
Tiziana Life Sciences
|
Jul 05, 2024 | HOLD |
Strong Buy
+489.2% avg upside
5 analysts
|
— | +69.9% |
|
MBIO
Mustang Bio
|
Jul 05, 2024 | HOLD |
Strong Buy
+905.8% avg upside
5 analysts
|
— | -97.5% |
|
SCLX
Scilex Holding Company
|
Jun 14, 2024 | BUY |
Strong Buy
+4351.2% avg upside
5 analysts
|
$140.00
1774.26% Upside
|
-75.8% |
|
XFOR
X4 Pharmaceuticals
|
May 17, 2023 | BUY |
Strong Buy
+496.4% avg upside
15 analysts
|
$4.00
5.13% Downside
|
-95.6% |
|
SCPX
Scorpius Holdings
|
May 05, 2023 | HOLD |
Strong Buy
+1664672.8% avg upside
11 analysts
|
— | -66.0% |
|
BIVI
BioVie
|
May 05, 2023 | HOLD |
Buy
+847.0% avg upside
6 analysts
|
— | -98.6% |
|
FLNA
Filana Therapeutics
|
May 05, 2023 | HOLD |
Buy
+2987.5% avg upside
4 analysts
|
— | · |
|
SEELQ
Seelos Therapeutics
|
Dec 30, 2022 | HOLD |
Buy
+46385614.3% avg upside
10 analysts
|
— | -100.0% |
|
GANX
Gain Therapeutics
|
Dec 30, 2022 | HOLD |
Strong Buy
+318.8% avg upside
9 analysts
|
— | -30.3% |
|
INMB
Inmune Bio
|
Dec 30, 2022 | HOLD |
Buy
+753.7% avg upside
11 analysts
|
— | -26.7% |
|
MNOV
Medicinova
|
Dec 15, 2022 | BUY |
Strong Buy
+460.6% avg upside
5 analysts
|
$6.00
354.55% Upside
|
-10.6% |
|
CMPX
Compass Therapeutics
|
Aug 19, 2022 | HOLD |
Strong Buy
+372.3% avg upside
19 analysts
|
— | +1433.5% |
|
ELOX
Eloxx Pharmaceuticals
|
Mar 31, 2022 | BUY |
Strong Buy
+153.9% avg upside
8 analysts
|
$120.00
758.35% Upside
|
-95.5% |
|
KRRO
Korro Bio
|
Mar 23, 2022 | BUY |
Strong Buy
+108.3% avg upside
19 analysts
|
$10.00
22.94% Downside
|
-49.2% |
|
BLFS
BioLife Solutions
|
Nov 12, 2021 | BUY |
Strong Buy
+13.0% avg upside
17 analysts
|
$67.00
157.35% Upside
|
-76.5% |
|
SRNE
Sorrento Therapeutics
|
Jul 02, 2021 | HOLD |
Strong Buy
+2272627.3% avg upside
7 analysts
|
— | -96.3% |
|
AKTX
Akari Therapeutics
|
Jul 02, 2021 | HOLD |
Strong Buy
+957.3% avg upside
7 analysts
|
— | -90.1% |
|
ABUS
Arbutus Biopharma
|
Jul 02, 2021 | HOLD |
Strong Buy
+94.1% avg upside
15 analysts
|
— | -22.0% |
|
GLMD
Galmed Pharmaceuticals
|
Oct 06, 2020 | HOLD |
Buy
+4115.6% avg upside
13 analysts
|
— | -87.1% |
|
IMVIF
IMV
|
Oct 06, 2020 | HOLD |
Buy
+2429509950.1% avg upside
7 analysts
|
— | · |
|
GRCE
Grace Therapeutics
|
Oct 06, 2020 | HOLD |
Strong Buy
+153.0% avg upside
9 analysts
|
— | -65.5% |
|
GALT
Galectin Therapeutics
|
Oct 06, 2020 | HOLD |
Strong Buy
+245.1% avg upside
8 analysts
|
— | -40.5% |
|
STRO
Sutro Biopharma
|
May 12, 2020 | HOLD |
Strong Buy
+31.8% avg upside
20 analysts
|
— | -44.7% |
|
FR:GNFT
Genfit
|
May 12, 2020 | HOLD |
Strong Buy
+189.2% avg upside
5 analysts
|
— | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.